CancerCoachLive invites you to join 2 expert hematology/oncology clinicians and a CLL patient for a 1-hour live, online, interactive discussion led by led by Dr. Matthew Davids, Associate Professor of Medicine, Harvard Medical School, Associate Director, Center for Chronic Lymphocytic Leukemia, Dana-Farber Cancer Institute.
This program will cover the challenges associated with BTK-inhibitor use in the treatment of CLL. Panelists will discuss the latest findings on long-term efficacy, side-effect management, and adopting healthy lifestyles to improve outcomes.
Watch this program and you will learn about:
- Available and recommended treatment options for CLL at all stages of disease
- Basic details about available BTK inhibitors from a patient’s perspective
- How patients and their caregivers can help align perspectives with healthcare providers
When you register, you may submit questions to the expert panel.